What is Catalyst Pharmaceutical's change in AP?

Catalyst Pharmaceutical (CPRX) reported change in AP of -$4.05M in Q1 2026.

How has Catalyst Pharmaceutical's change in AP changed year-over-year?

Catalyst Pharmaceutical's change in AP increased by 24.9% year-over-year, from -$5.4M to -$4.05M.

What is the long-term trend for Catalyst Pharmaceutical's change in AP?

Over 2 years (2022 to 2024), Catalyst Pharmaceutical's change in AP has grown at a 22.1% compound annual growth rate (CAGR), from $1.21M to $1.8M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Catalyst Pharmaceutical CPRX Change in AP

Change in AP at other companies

PTC TherapeuticsPTCT

-$68.71M-471%

Edgewise Therapeutics, Inc.EWTX

$1.45M-49.4%

Acadia PharmaceuticalsACAD

$1.34M-29.4%

Dyne Therapeutics, Inc.DYN

-$4.8M+44.1%

Scholar RockSRRK

-$1.09M+80.8%

Amneal Pharmaceuticals, Inc.AMRX

-$124.58M-10.6%

Other financials

Income statement

See full

Revenue$149.4M+5.6%

Gross profit$134.9M+9.2%

Operating income$73.2M+15.6%

Net income$63.7M+12.3%

EPS (diluted)$0.50+11.1%

Balance sheet

See full

Cash & equivalents$755.9M+30.2%

Total debt$2.7M-13.3%

Total equity$1.0B+27.5%

Total assets$1.1B+26.3%

Cash flow

See full

Operating cash flow$59.6M-0.8%

CapEx$27.0K—

Free cash flow$59.6M-0.8%

Valuation

See full

Market cap$3.84B+2.7%

Enterprise value$3.09B-4.1%

P/E17.4×-1.6×

P/S6.4×-0.6×

Profitability

See full

Gross margin86%-0.2pp

Operating margin44.8%+1.6pp

Net margin37.1%+0.2pp

FCF margin34.9%-15.2pp

Returns & leverage

See full

Return on equity24.5%-4.6pp

Debt / equity0×0.0×

Current ratio7.1×+1.0×

Where this comes from

Reported directly by Catalyst Pharmaceutical in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Catalyst Pharmaceutical's change in AP?: Catalyst Pharmaceutical (CPRX) reported change in AP of -$4.05M in Q1 2026.
How has Catalyst Pharmaceutical's change in AP changed year-over-year?: Catalyst Pharmaceutical's change in AP increased by 24.9% year-over-year, from -$5.4M to -$4.05M.
What is the long-term trend for Catalyst Pharmaceutical's change in AP?: Over 2 years (2022 to 2024), Catalyst Pharmaceutical's change in AP has grown at a 22.1% compound annual growth rate (CAGR), from $1.21M to $1.8M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.